Elevated levels of interleukin-1β (IL-1β) and interleukin-1 receptor antagonist (IL-1 Ra) have been detected in subjects with essential hypertension [18–21] and they are known to contribute to the development of insulin resistance and MetS [18, 22]. The gene discussed is IL1B; the disease is metabolic syndrome.